Cargando…

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration

Tumor biomarkers including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67 are routinely tested in breast cancer patients and their status guides clinical management and predicts prognosis. A few retrospective studies have suggested that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xingchen, Zhang, Junyong, Yun, Haiqin, Shi, Ranran, Wang, Yan, Wang, Wei, Lagercrantz, Svetlana Bajalica, Mu, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742218/ https://www.ncbi.nlm.nih.gov/pubmed/26384297

Ejemplares similares

Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy
por: Yun, Haiqin, et al.
Publicado: (2014)

Alterations of lymph nodes evaluation after colon cancer resection: patient and tumor heterogeneity should be taken into consideration
por: Guan, Xu, et al.
Publicado: (2016)

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies
por: Altena, Renske, et al.
Publicado: (2022)

Valve positions upon which cardiac surgeons operate should be taken into consideration
por: Wang, Tsu-Hsien, et al.
Publicado: (2023)

Should the biofilm mode of life be taken into consideration for microbial biocontrol agents?
por: Pandin, Caroline, et al.
Publicado: (2017)

Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors
por: Yang, Jianjun, et al.
Publicado: (2013)

How Milk Should Be Taken
por: Duckworth, Dyce
Publicado: (1881)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Reply to Kratz et al.
por: Frebourg, Thierry, et al.
Publicado: (2020)

Should valproate be taken during pregnancy?
por: Eadie, Mervyn J, et al.
Publicado: (2005)

What Should be Taken into Consideration for a Meta-Analysis of Green Tea Consumption and Stomach Cancer Risk?
por: Kim, Jeongseon
Publicado: (2010)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
por: Fransson, Åsa, et al.
Publicado: (2016)

Resistance to apoptosis should not be taken as a hallmark of cancer
por: Wang, Rui-An, et al.
Publicado: (2014)

Awake Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Which Clinical Issues Should Be Taken Into Consideration
por: Yu, Xin, et al.
Publicado: (2021)

Why the Transitivity of Perceptual Simultaneity Should be Taken Seriously
por: Arstila, Valtteri
Publicado: (2012)

Caution should be taken when using electronic health record database
por: Wang, Lina, et al.
Publicado: (2019)

COVID-19 should not be taken lightly — Mitigation at the end of the lockdown
por: Pal, Shrayan
Publicado: (2020)

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
por: Cottin, Vincent, et al.
Publicado: (2022)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
por: Omran, Meis, et al.
Publicado: (2020)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

Orthopaedic training during COVID-19 pandemic: should action be taken?
por: Abdelazeem, Ahmed Hazem, et al.
Publicado: (2022)

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??
por: Kaloyannidis, Panayotis, et al.
Publicado: (2022)

Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
por: Kwiecinska, Anna, et al.
Publicado: (2014)

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2021)

Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension
por: Spoladore, Roberto, et al.
Publicado: (2017)

Corruption should be taken into account when considering COVID-19 vaccine allocation
por: Spreco, Armin, et al.
Publicado: (2022)

Which neoadjuvant chemotherapy regimen should be recommended for patients with advanced nasopharyngeal carcinoma?: A network meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2018)

Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken
por: Alberti, Adriano, et al.
Publicado: (2021)

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
por: Glynne-Jones, R, et al.
Publicado: (2006)

Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account
por: Smith, Margaret, et al.
Publicado: (2018)

Letter to the Editor: “Orthopaedic training during COVID-19 pandemic: should action be taken?”
por: Dixit, Shaili, et al.
Publicado: (2022)

Straatsma Syndrome: Should Visual Prognostic Factors Be Taken into Account? A Case Report
por: Sevik, Mehmet Orkun, et al.
Publicado: (2021)

Anti-anonymity should not be taken more seriously than other positions on gamete donation
por: Pennings, Guido
Publicado: (2023)

Effects of Neoadjuvant Chemotherapy on Benign Breast Lesions Compared to Cancers: Should an Additional Lesion on Magnetic Resonance Imaging Responding Similar to Cancer after Neoadjuvant Chemotherapy be Viewed with Suspicion?
por: Leddy, Rebecca, et al.
Publicado: (2016)

Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy
por: GEZER, UGUR, et al.
Publicado: (2014)

Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
por: Kurata, Yoshihiro, et al.
Publicado: (2021)

Should Now Receive Consideration
Publicado: (1897)

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2022)

Retrospective Studies with Inconsistent Data: Results, Conclusions and Recommendations should be taken with a Grain of Salt
por: AlTraif, Ibrahim
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t8j4g4q8k3ju148ebp2h14bkgd